Sutro Biopharma STRO Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's total operating expenses?
- Sutro Biopharma (STRO) reported total operating expenses of $44.18M in Q1 2026.
- How has Sutro Biopharma's total operating expenses changed year-over-year?
- Sutro Biopharma's total operating expenses decreased by 48.6% year-over-year, from $85.91M to $44.18M.
- What is the long-term trend for Sutro Biopharma's total operating expenses?
- Over 4 years (2021 to 2025), Sutro Biopharma's total operating expenses has grown at a 12.9% compound annual growth rate (CAGR), from $160.4M to $260.85M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.